| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  PLANTEDIT Our mission is to produce non-transgenic, regulatory free, sustainable, consumer oriented genome edited plant products. PLANTeDIT is the first biotech company dedicated to use patented next generation genome editing tools CRISPR/Cas9 RNPs® from our key collaborator Toolgen (http://toolgen.com/?lang=en) with our transformation technology for efficient direct delivery and swift regeneration of genome edited plants. Our mission is also to revolutionize plant transformation technology with our innovative, universal, cost effective, swift transformation system applicable to broad a range of crop species for direct delivery of genome editing tools. Further, PLANTeDIT aims to develop highly pure mammalian protein and human drugs at cost … Type: | 1 | 0 | 0 | 1 |
 |  Nuritas See Nature Differently Through pioneering life science and artificial intelligence, we developed our unique Nuritas MagnifierNπΦ platform that allows us to identify, unlock, clinically test and patent peptides; turning them into powerful and precise ingredients that elevate natural efficacy. We want to empower people to live healthier lives, naturally by making our everyday products healthier, safer, greener and more efficacious. From what we eat, to what we apply to our skin. By translating nature’s wisdom into innovation, together, we can change the life of billions. Bioactive Peptide discovery and development, Pure peptides, Peptide mixtures, Hydrolysates, Multi targeted peptides, Bioinformatics, Artificial … Type: | 23 | 5 | 10 | 54 |
 |  Sensorion Our mission: find solutions for hearing disorders Sensorion is a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders Its clinical-stage portfolio includes one Phase 2 product: SENS-401 (Arazasetron) progressing in a planned Phase 2 proof of concept clinical study of SENS-401 in Cisplatin-Induced Ototoxicity (CIO) and, with partner Cochlear Limited, a study of SENS-401 in patients scheduled for cochlear implantation. Sensorion has entered into a broad strategic collaboration with the Institut Pasteur focused on the genetics of hearing. It has two gene therapy programs … Type: | 15 | 9 | 6 | 76 |
 | SQI Fostering medical innovation For a safer and more effective healthcare, come develop tomorrow’s technological solutions with us. Software development of medical technologies: From proof of concept to certified product, we design, develop and test your medical devices software, in compliance with IEC 62304. Surgical planning | Guidance of surgical gestures | Medical robotics | Healthcare data & business wokflow management Tailor-made support for quality and regulatory affairs, from research to market: Certify your medical innovation in the best optimized and most secure way. Regulatory strategy | Clinical investigation | CE/FDA certification Développement de logiciels médicaux / applications cliniques , Quality … Type: | 10 | 4 | 8 | 84 |
 | Medimprint Tissue fingerprinting as an innovation to better diagnose and treat brain diseases Medimprint develops innovative, non-lesion medical devices, for clinical research in brain tumors and neurodegenerative diseases. Based on a new concept, “the brain tissue imprint”, Medimprint’s products are the new generation of companion medical devices for personalized and targeted therapies. The non-lesion feature of this concept allows an exclusive in vivo access to : - Tumor heterogeneity - Peritumoral regions - Neurodegenerative regions for poly-omic molecular analyses. Medimprint’s technology breakthrough relies on the integration of functionalized silicon chips to surgical stylet for atraumatic sampling. Through an original « hide … Type: | 6 | 1 | 7 | 5 |
 | Voxcan Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and … Type: | 6 | 1 | 5 | 16 |
 | Kallistem Kallistem is a biotech company specialized in spermatogenesis. The company was founded in 2012 with the objective to anticipate and treat male infertility. It promotes a technology and expertise developed by Philippe Durand and Marie-Helene Perrard, two internationally renowned scientists in the field of the reproductive biology and more specially in in vitro spermatogenesis. Kallistem has developed, in collaboration with its partners, original and innovating technologies of germinal cell culture for male fertility preservation and the treatment of male infertility. male fertility, cellular therapy, biology of reproduction, and testicular toxicology Type: | 0 | 0 | 0 | 3 |
 | Cure51 We want every patient to become a Cancer Survivor. The first worldwide clinical and molecular database of exceptional survivors leading the path to new therapies against cancer. Type: | 5 | 3 | 2 | 28 |
 | ONCOMECA Early diagnosis of skin cancers has never been that easy! ONCOMECA is a class IIb medical device according to the EU regulation 2017/745. Our technology lies in the identification of early skin cancers using their mechanical markers combined to their visual characteristics. Our expertise has been miniaturized and automatized to provide an easy-to-use and 90% reliable technology! Type: | 0 | 0 | 0 | 1 |
 | Biomeca® Creator of solutions *A deep expertise in Biomechanics and Surface Analysis in Life Science* Living systems has to be considered as physical systems so that unravelling the physical mechanisms involved in complex biological processes and diseases is one of the main challenges of biology. In BioMeca we believe that the starting point is to give a quantitative physical description of biological samples to have a better understanding of such processes. BioMeca® is a company based in Lyon expert in biomechanics and mechanobiology and specialized in high-resolution structural and mechanical characterization of biological samples at different scales, from large structures, such … Type: | 8 | 3 | 5 | 7 |
 | ENTEROSYS - Gut Is The Link Preclinical studies in gut and gut brain for therapies of tomorrow 🔬 About ENTEROSYS At ENTEROSYS, we are science enthusiasts 🧪 driven by a conviction deeply rooted in medical history: for over two millennia, it has been acknowledged that the key to understanding many diseases lies in our digestive system and its interactions with other organs. Based on this ancient wisdom, we have embraced a modern and holistic approach focused on digestive physiology and the communication between the gut and peripheral organs. Specializing in the preclinical evaluation of compounds with therapeutic potential 💊, we utilize cutting-edge techniques to analyze physiological … Type: | 1 | 1 | 0 | 10 |
 | IPRASENSE Cell Culture Monitoring Instruments IPRASENSE revolutionizes cell analysis with innovative technologies for automated cell counting and real-time visualization, ideal for research and quality control. Cell culture monitoring, Lensless Lensfree Imaging, Video microscopy, Time lapse Imaging, Automatic cell count and viability analysis, High throughput cell, Inside your incubator, cell count, cell counting, cell viability, cell viability analysis , cell monitoring, and angiogenesis Type: | 1 | 0 | 0 | 6 |
 | SC MEDICA SC MEDICA is a global leading spinal facet fixation company, dedicated to providing innovative solutions for back pain control and spinal fusion. With a commitment to excellence and innovation, SC MEDICA strives to advance standards of care and address unmet patient needs. Our mission: Raise awareness about the role of facet joints in a large number of spinal conditions. Make FFX® fusion a gold standard. Worldwide. Type: | 1 | 1 | 0 | 7 |
 | SkinDermic Clinical stage biotech company with innovative first-in-class new treatments in virology and dermatology SkinDermic® is a drug discovery company focused on developing breakthrough and innovative small molecule drugs for the treatment of HHV8 virus linked neoplasia and inflammatory skin diseases. SkinDermic® recently completed proof of concept clinical phase in humans with its First-in-Class treatments for acne and HHV8 associated diseases (Kaposi Sarcoma and Lymphomas). Skindermic owns now a pipeline with very active and very well tolerated new drugs for HHV8 associated diseases and acne vulgaris. Type: | 0 | 0 | 0 | 5 |
 | The Twinkle Factory Stain Different. Tag FAST. The Twinkle Factory offers exclusive twinkling reagents for life science research: flurogenic ligands for FAST and split FAST, protein fluorescent reporters, and fluorogenic molecular glues for CATCHFIRE, a self reporting protein dimerizer. Protein-protein interactions, high content analysis, anaerobe metabolic engineering, are our users keywords. The Twinkle Factory is dedicated to speed-up the dissemination of breakthrough fluorescent technologies across the life sciences community. molecular glues, protein-protein interactions, and fluorescent proteins Type: | 0 | 0 | 0 | 6 |
 |  ViroScan3D Solutions Personnalisées de Génomique ViroScan3D is a service provider in genomic and micro-genomic located in Lyon. We have ten year experience in genome scale analyses from sample preparation to data analysis. During those years we have developed specific processes dedicated to complex samples (low quality and quantity samples). We propose our services for -Molecular broad spectrum identification of infectious agents, new agents, resistance mutants by whole genome sequencing of viruses and microorganisms (bacteria, yeast, fungi, etc.) -Analysis of complex populations using the metagenome, virome, bacteriome approach to identify the different agents in the population and their proportions -The identification of … Type: | 0 | 0 | 0 | 2 |
 | Adjuvatis Built around safe-by-design concept, Adjuvatis is committed for innovative formulations to improve pharmaceuticals Adjuvatis, a French startup in biotechnology, develops innovative safe-by-design delivery systems to help laboratories and pharmaceutical companies in vaccine formulation as adjuvants and in drug delivery as vectors for oncology, dermatology, infections, etc. Our first technology, called i-Particles®, is based on 200 nm-diameter particles composed of poly-lactic acid only (any surfactant and solvents) for formulation of hydrophobic molecules in the particle core and surface functionalization of peptides. Our second technology, i-LipoP®, consists in i-Particles® covered by lipidic bilayers at their surface for vectorization of nucleic acids and … Type: | 2 | 0 | 2 | 4 |
 | BIOMILLENIA Microbiology assays at previously impossible speeds and strain banks with amazing diversity ! Microbiology is what we do. Our unrelenting focus has enabled us to develop unique capabilities in ultra-high-throughput single-cell culture of microorganisms. Businesses in areas as diverse as pharma, agriculture, food, human health and environmental protection have partnered with us to gain powerful competitive advantages from our technology.So could yours. Our proprietary microfluidic platform is capable of : - identifying microbes of interest based on their functional characteristics among millions of candidates - perform a wide range of assays at previously impossible speeds - generate strain banks with … Type: | 0 | 0 | 0 | 5 |
 | Synens Intelligent Drug Screening Synens is a French company that manufactures rapid on-site drug screening devices. We strive to deliver reliable and customizable drug test kits and analyzers. At Synens, adaptability is key. We meet the requirements of our clients and the regulations in force. Synens is the designer of the D1 Handheld Analyzer that is used internationally by law enforcement, fire departments, healthcare professionals and in workplaces. Technology, Drug Screening, and Drug of Abuse Detection Type: | 0 | 0 | 0 | 1 |
 | SynHelix (now Quantoom Biosciences, a Univercells Company) Large-scale DNA synthesis technology that harnesses natural enzymes. Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information. Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnology Type: | 2 | 2 | 1 | 122 |
 | OxiProteomics Innovative scientific services on efficacy testing for bioactives or formulated products to support healthy aging. OxiProteomics is a technology-based start-up committed to promoting the healthy living and healthy aging of human population. We deliver proven science services to dermo-cosmetic and food industries to support marketing claims. We also offer environmental quality bio-monitoring solutions to promote sustainable development. OxiProteomics patented technologies are based on the direct and specific detection of functional high quality proteins vs. oxidatively damaged (carbonylated) in biological samples, with a remarkably specificity and sensitivity. We can detect and quantify for the first time, the quality of thousands proteins … Type: | 3 | 1 | 2 | 14 |
 | ALPIONER Therapeutics Building a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance Alpioner Therapeutics is a biotech company developing a whole-cell vaccine platform consisting of genetically optimized strains of human pathogens undergoing an attenuation process which delivers a Killed but Metabolically Active (KBMA) vaccine substance. This platform has already generated a first candidate targeting a human multi-resistant pathogen, Pseudomonas aeruginosa. It carries on the potential for further applications against other resistant pathogens. Alpioner Therapeutics mission is to build a pipeline of immuno-infectiology candidates to fight against anti-microbial resistance (AMR). Type: | 18 | 4 | 1 | 3 |
 | Natura Meliss' [Automatic translation follows] A zero-waste and natural bathroom “Mixed, healthy and effective products based on Ayurvedic plants” The idea of Natura Méliss’ was born after a 15-year experience as an engineer in a pharmaceutical Research and Development laboratory. I was not convinced by the cosmetics I found on the market. So I decided to look for solutions. I discovered Ayurvedic medicine a few years ago. Ayurveda, or Ayurvedic Medicine, is a therapeutic system created in India about 5000 years ago. In Sanskrit the word “Ayurveda” is a combination of two words “ayur”, which means “life” and “veda”, which means “science”. … Type: | 1 | 1 | 0 | 1 |
 | GlycoBAR GlycoBAR: a new and cost effective way to get rid for blood group antibodies. No blood group barrier any more ! GlycoBAR sells blood group antigen ligands that can be used to make plasma "Universal" (=compatible with all recipients, whichever the blood group of the donor is). Our ligands are also allowing transplant of organs when donor and recipients are belonging to incompatible blood group Biofermentation, Blood purification, Blood group antibody removal, and Isoagglutinins removal Type: | 4 | 4 | 0 | 4 |
 | Hydroxide Technologies [Automatic translation follows] Design / Manufacturing of Fuel Cell Testing Equipment & Fuel Cell System Engineering Design / Manufacturing of Fuel Cell Testing Equipment & Fuel Cell System Engineering Hardware Electronics, Control/Command, Fuel Cell System, UI design, and Embedded System Type: | 2 | 0 | 0 | 4 |
 | NOXELIS Innovative ocular solutions Noxelis is a French ophthalmic medical device company dedicated in developing next-generation treatments, including polymers and hyaluronic acid as a cornerstone. Through its technological platform, Noxelis proposes different formulations aimed at improving medical practice and provides ophthalmologists with first-in-class therapies to treat ocular surface diseases. Noxelis was founded by a passionate and determined team to bring innovative technologies to market with one focus: Bring patients' ocular comfort to the next level. Type: | 2 | 2 | 0 | 4 |
 | G.CLIPS biotech ENABLING TECHNOLOGY FOR THERAPEUTICS TARGETING MEMBRANE PROTEINS G.CLIPS biotech created the first enabling technology to unravel the potential of drug and antibody candidates on pathology-like format membrane proteins to be used in screening efforts, characterization, structural studies, mechanism of action, pharmacological profiling and target validation. We offer a unique technology to express, stabilize, select and validate membrane proteins as targets based on proprietary G.Screen® Platform. G.Mixes® G.Select® Assay G.Lipidomics® G.Validation® Assay We provide tailor-made services to pharma, biotech and animal health companies targeting membrane proteins (GPCRS, Receptors, Transmebrane Proteins) that would like to ascertain the necessary environment and conformation stabilization … Type: | 12 | 2 | 6 | 6 |
 | CLARTEIS Clarteis is a global specialist in the miniaturization and manufacture of medical devices dedicated to dermatology. CLARTEIS is a global leader in manufacturing advanced and innovative technologies for the Dermatological market. CLARTEIS team is specialized in developing miniaturized and high quality light-based medical devices to provide to Dermatologists worldwide. Type: | 0 | 0 | 0 | 11 |
 | AnatomikModeling 3D custom made implants AnatomikModeling creates 3D custom-made implants for Reconstructive&Aesthetic Surgery, Pneumology and Maxillofacial Surgery. Our 3D custom-made implants are designed for Pectus Excavatum, Poland Syndrome and others anatomy defects like hard or soft tissues loss. Medical Devices, Reconstructive surgery, Pectus Excavatum surgery, Poland Syndrome surgery, and 3D CAD CAM Medical implants Type: | 0 | 0 | 0 | 4 |
 | AbLeads AbLeads is a young biotech startup developing innovative solutions in Oncology, through the generation of novel, personalized therapeutic antibodies. Learn More on https://ableads.fr Biotechnology, Oncology, Immunotherapy, Therapeutic Antibodies, and Personalized Medicine Type: | 0 | 0 | 0 | 1 |
 | IPSOMEDIC Innovative Process Solutions IPSOMEDIC is a pharmaceutical development company, specializing in innovation in the manufacturing of active pharmaceutical ingredients (APIs). Our objective is to give countries the possibility to reach their pharmaceutical independance. We design tailor-made processes for all stages of industrial production, to become cost efficient, environmental-friendly, and safe: - Continuous chemical reaction - Continuous purification - Continuous crystallization Innovation, Chemical processes, drug substance, and Continuous processes Type: | 2 | 0 | 0 | 17 |
 | Syntivia Preclinical and R&D expertise for skin health care Syntivia is a research laboratory that creates and develops active compounds for dermatology and cosmetics in partnership with its customers. Our experts use the latest chemistry and extraction tools and techniques to create effective active compounds. We develop our own skin models and use the latest cellular/molecular biology and imaging techniques to build solid scientific dossiers demonstrating product efficacy. Syntivia est Laboratoire de rechercher qui créé et développe en partenariat avec ses clients des composés actifs pour la dermatologie et la cosmétique. Nos experts mettent en œuvre les derniers outils et techniques … Type: | 0 | 0 | 0 | 10 |
 | INFYNITY BIOMARKERS SAS Maximizing Immunoassays Performances InfYnity Biomarkers was founded in 2009 in Lyon (France). We are an R&D In-Vitro Diagnostics Company fully dedicated to infectious diseases and immunity. Company Mission: Maximizing Immunoassay Performance i.e. we have the ambition to set new criteria for immunoassays: study the diversity of immune response to provide high-value information instead of the binary response. Our Offer: - High quality, custom-made biomaterial (antigens and antibodies) - RUO Multiplex Immunoassays - Tailored immunobiology services ranging from biomaterial design to biomarker discovery and immunoassay development. Our originality and strength relies on a unique combination of proven skills: Multiplex technology AND … Type: | 0 | 0 | 0 | 6 |
 | GutyCare Digital therapeutics & patient monitoring solutions specialized in gastroenterology and immunology We develop Digital Support Programs and Digital Therapeutics for patients suffering from digestive pathologies (IBS, IBD, Cancer...) Type: | 4 | 2 | 2 | 6 |
 | Biomaneo, a Shimadzu group company [Automatic translation follows] A Shimadzu group company Biomaneo specializes in the design and marketing of innovative medical analysis kits based on the fine analysis of proteins by mass spectrometry for neonatal screening and the diagnosis of various pathologies in hospital laboratories. Screening and Diagnosis, Mass Spectrometry, Medical Device, and Biological Markers Type: | 0 | 0 | 0 | 16 |
 | Delaware Humane Association Founded in 1957, Delaware Humane Association (DHA) is a nonprofit no kill animal shelter and adoption center serving a four state area. We make "friends for life" by connecting people with animals, and by building strong relationships to better serve our community. We envision a day when every animal is loved, has a home, and has a "friend for life." At DHA, we make "friends for life" by: * Matching the right people with the right animals * Offering a friendly, welcoming environment * Empowering others to care for animals * Being kind, caring and compassionate Each year, hundreds of … Type: | 1 | 0 | 1 | 16 |
 | Longevity Veterinary Center - Holistic Pet Care Bringing together the most power conventional and holistic tools to help your pet to live longer and live better. At the Longevity Veterinary Center we integrate conventional and holistic modalities to give your pet the health and wellness they deserve. Our facility in Whippany, NJ is a state-of-the-art wellness center treating pets of all kinds, including exotics. Our goal is to help your pet to live longer and live better. Longevity Veterinary Center offers both conventional and integrative wellness services, as well as holistic treatment options including chiropractic care, acupuncture, nutritional consultations, non-anesthetic dentistry (NAD), stem cell therapy, ozone therapy, … Type: | 0 | 0 | 0 | 16 |
 | PacBio Our mission is to enable the promise of genomics to better human health. At PacBio, we’re devoted to empowering you. Pioneering the future through biology takes vision. You have to look beyond the status quo to what’s possible. We know your vision can reveal the full potential of the genome, advance human health and the health of our planet. And that is why your vision and pursuit are at the very center of what our company does — our product design, our customer support model, our partnerships, and even our identity. We create the world’s most advanced sequencing systems to … Type: | 5 | 1 | 3 | 694 |
 | Conception Turning stem cells into human eggs Working on turning stem cells into human eggs Type: | 4 | 0 | 3 | 50 |
 | Creo Medical An Advanced Energy company developing technology & medical devices to improve patient outcomes in Therapeutic Endoscopy. At Creo Medical we are dedicated to improving patient outcomes by bringing advanced energy to therapeutic endoscopy. Our integrated electrosurgery unit delivers Bipolar Radiofrequency for precise dissection and resection and Microwave energy for controlled ablation and coagulation. This technology sets a new standard for Endoscopic Submucosal Dissection with our new Speedboat RS2 instrument: the Bipolar Radiofrequency cut allows precise dissection and the microwave coagulation provides controlled haemostasis while the protective hull reduces the risk of muscle damage and the integrated injection needle helps to … Type: | 0 | 0 | 0 | 208 |
 | Myomo, Inc. Offering expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Myomo, Inc. is a medical myoelectric company that offers expanded mobility for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces (orthoses) to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuro-muscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is the only device that, sensing a patient’s own neurological … Type: | 3 | 0 | 3 | 132 |
 | Seratec [Automatic translation follows] Your CDMO for API solutions since 1970 | Our excellence, your trust #OEYT At Seratec, APIs are more than a science. They are a passion. Entrepreneurs in pharmaceutical chemistry since 1970, we produce active pharmaceutical ingredients (APIs) for the treatment of rare and orphan diseases. With internationally recognized French know-how, we design, develop, produce and register dossiers for pharmacologically active molecules with the American (FDA), European (EMA) and national (ANSM) drug agencies. To offer the best services, we also ensure the production of APIs according to the quality standards known as Good Manufacturing Practices (GMP 2 or … Type: | 9 | 0 | 9 | 26 |
 | QUANTA MEDICAL [Automatic translation follows] 33 years of clinical research in Pharma, Medical Device & Dermo-Cosmetics QUANTA MEDICAL Sharing experience CRO since 1986. 30 years of consulting and operational services in clinical research and observational studies, 30 years of presence in Europe and on the African continent alongside the pharmaceutical, agri-food, dermatological, cosmetic and medical device industries, 30 years of know-how in Human Health reinforced by: - a double ISO 9001 & 27001 certification - dedicated technical tools (QUANTA VIEW®, E-CRF, Trial-On-Line®) Clinical Research / Clinical Trial, e-CRF, Epidemiological Study, Data Management / Biometrics, Medical Writing, Health IT Development, Health Risk Assessment, … Type: | 0 | 0 | 0 | 9 |
 | Tacalyx GmbH Tacalyx develops the next generation of anti-Cancer therapeutics in indications with high medical need Type: | 3 | 0 | 3 | 13 |
 | VANETTA FOOD [Automatic translation follows] We are soooo traditional. 0% ANIMALS, 100% VEGETABLE. Vanetta Food is a Foodtech startup that was born in 2023 to bring together terms as opposite as tradition and innovation. We are inspired by the flavour of our culture to make a diet for everyone with vegetable meat possible in the form of new products that do not exist on the market. Our value proposition is to create a sustainable, vegetable-based diet with a high protein content in the first plant-based meat factory in Galicia. Type: | 0 | 0 | 0 | 8 |
 | Alchemab Therapeutics Ltd Pioneering Patient-led Antibody Therapeutics Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and development. Alchemab takes an unbiased and function-first approach using three complementary processes and cutting-edge technologies to identify naturally protective antibodies. Alchemab’s engine is enabled through collaborations with patient representative groups and biobanks around the world with whom we partner to further our understanding of disease. Antibody Therapies, Immunology, and Neuro-dengeneration Type: | 4 | 1 | 3 | 59 |
 | IMAI MedTech Adding the 3rd dimension to the detection of cancer IMAI is committed to improving cancer diagnostics by specializing in a rapid and automated tissue preparation approach, including digital tissue visualization of biopsies. IMAI strives to bring about a groundbreaking change in histology. The solution developed by IMAI avoids the time-consuming manual cutting of tissue into micrometer-thin slices. On the one hand, this enables complete quantification of the entire biopsy and, on the other hand, the digital 3D images support pathologists in their diagnosis with algorithms. Vision: To achieve 100% accuracy in cancer diagnostics. Mission: To drive a paradigm shift in … Type: | 1 | 0 | 1 | 13 |
 | HemostOD Inspired by platelet biology to save lives. We engineer and manufacture platelets. platelets, biotechnology, bioengineering, stem cells, on demand, biodrug, in vitro manufacturing, Bioprocess, blood platelets, alloimmunization, thrombocytopenia, blood cancer, leukemia, transfusion, HSCT, Stem cell, Hematology, biologics, drug, biopharma, drug development, healthcare, allogenic therapy, drug delivery, miRNA, siRNA, targeted delivery, and targeted drug delivery Type: | 2 | 0 | 0 | 9 |
 | BioPorto Diagnostics A/S BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem. The Company’s flagship products are based on the NGAL biomarker and designed … Type: | 0 | 0 | 0 | 47 |
 | Bright Peak Therapeutics Better Biologics Through Chemistry Bright Peak are developing a portfolio of first-in-class and best-in-class cytokines with optimized biological properties for the treatment of cancer and autoimmune diseases. Through a variety of proprietary technology platforms, Bright Peak is uniquely abled to conjugate its cytokines as payloads to antibodies, creating bespoke, novel and proprietary “Bright Peak Immunocytokines”, and to other cytokines as “duokines”. The Bright Peak Immunocytokines allow tissue- and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy. One of the many advantages of our approach is its "off-the-shelf" feature. Using a pioneering site-specific ADC-like chemical … Type: | 1 | 0 | 0 | 55 |
 | Augustine Therapeutics Innovative Therapies for Neuromuscular and Neurodegenerative Disorders Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT), peripheral neuropathies and neurodegenerative disorders. The company is rooted in the ground-breaking research at VIB and KU Leuven and supported by Asabys Partners, Eli Lilly and Company, V-Bio Ventures, PMV, AdBio Partners, VIB, Gemma Frisius Fund and CMT Research Foundation. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge … Type: | 0 | 0 | 0 | 15 |
 | Medannex Ltd Award-winning Scottish biopharmaceutical company, advancing the treatment of cancers and autoimmune diseases. Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology. Antibody development, Innovation, Biotechnology, T cell modulation, Skills development, Autoimmune diseases, Inflammation, Lupus, SLE, Collaboration, … Type: | 2 | 0 | 2 | 10 |
 | Herantis Pharma Plc. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s. Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’ lead product HER-096, is an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein. It combines the compelling mechanism of action of CDNF with the convenience of subcutaneous administration. A Phase 1a clinical trial has demonstrated a good safety and tolerability profile, and efficient blood-brain barrier penetration of subcutaneously administered HER-096 in humans. The shares of Herantis are listed on the Nasdaq First … Type: | 1 | 0 | 1 | 21 |
 | e-therapeutics PLC Computing the future of medicine A specialist in computational drug discovery with a focus on developing RNA interference (“RNAi”) therapeutics Type: | 0 | 0 | 0 | 52 |
 | PharmNovo Innovation in pain relief PharmNovo AB is a clinical-stage pharmaceutical company focused on developing safe and effective drugs for neuropathic pain. In this area, there is currently a lack of sufficient treatments. The company’s drug candidate, PN6047, effectively reduces neuropathic pain in animal models and the findings from the Phase I trial show that PN6047 is safe and well-tolerated at the doses tested, with no serious adverse events reported. Furthermore, PN6047 exhibited none of the adverse events typically associated with the conventional opioids like oxycodone and morphine, such as respiratory depression, constipation, itching, or signs of abuse potential. This validates … Type: | 0 | 0 | 0 | 10 |
 | CellCentric Developing inobrodib (CCS1477), first-in-class p300/CBP inhibitor to treat specific cancers. Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise … Type: | 2 | 1 | 1 | 23 |
 | 4D Biomaterials 4Degra® 3D printing biomaterials - helping people heal. Regenerative, resorbable and customisable. The market for polymeric biomaterials is growing quickly, but despite this growth, it is widely recognised in the industry that the ‘holy grail’ solution has not yet been developed. The ideal biomaterial for use in regenerative medicine must: be biocompatible; promote tissue regeneration; have non-toxic biodegradation, have mechanical properties suited to the host tissue and good handling properties in a clinical environment. Our people have developed a patented range of novel polymeric 3-D printing resin-inks that promise, uniquely, to meet all of the above requirements and offer important … Type: | 0 | 0 | 0 | 9 |
 | ARGONAUTE RNA LIMITED Argonaute RNA Ltd. is developing safe and reliable methods of temporarily silencing target genes in different tissue cells. Argonaute RNA is pursuing a number of therapeutic opportunities in RNA interference. RNAi harnesses a cell mechanism that inhibits the expression of a specific gene and thereby inhibits the production of a specific protein. Argonaute RNA research projects build on existing intellectual property. We show how our proprietary modification of small interfering RNA (siRNA) allows safe and effective ways to silence specific gene expression. We use a novel method of stabilising the siRNA and thereby avoid a range of issues which have … Type: | 0 | 0 | 0 | 10 |
 | Integra Therapeutics Integra Therapeutics is a biotech company engineering the next generation of gene writing tools to cure genetic diseases At Integra Therapeutics we have combined the precision of CRISPR systems with the gene transfer efficiency of viral integrases and transposases. Harnessing what nature has evolved to introduce large pieces of DNA into the genome, together with the precision of sequence specific DNA binding proteins, has allowed for unprecedented efficiency in programmable gene delivery. Type: | 2 | 1 | 1 | 20 |
 | Draupnir Bio Bringing innovative therapies to patients Draupnir Bio is a Danish biotechnology company driven by a deep commitment to scientific excellence and the desire to bring innovative therapies to patients in need. By harnessing the natural machinery of the lysosome, we are developing oral, small molecule degraders of extracellular pathogenic proteins – the next frontier of targeted protein degradation (TPD), a rapidly emerging field that exploits a cell’s own destruction machinery to tackle disease-causing proteins that have historically been highly challenging to target with conventional therapies. First-generation TPD approaches are exclusively limited to intracellular targets, leaving extracellular and membrane-bound proteins – … Type: | 0 | 0 | 0 | 16 |
 | Pan Cancer T Pan Cancer T is a biotechnology company developing T cell receptor (TCR) T-cell therapy for solid tumors. Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges. Type: | 1 | 1 | 0 | 9 |
 | SciRhom Targeting iRhom2 for better treatment of autoimmune diseases SciRhom GmbH, based in IZB Martinsried, Germany, is a biotech start-up company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening diseases. Founded in late 2016, we develop first-in-class antibodies against iRhom2, a key modulator of several crucial pro-inflammatory signalling pathways, including TNF-alpha signalling. Following the preclinical and early clinical development of these monoclonal antibodies, we are aiming to provide superior treatment options to currently existing inhibitors of TNF-alpha signaling. SciRhom is poised to transform the lives of patients with autoimmune diseases. drug … Type: | 3 | 2 | 2 | 16 |
 | Asceneuron SA Targeting the root cause of neurodegeneration Asceneuron is a clinical stage biotech company focused on the development of orally bioavailable therapeutics for debilitating neurodegenerative disorders with high unmet medical need. The pipeline reflects our ambition to develop treatments for a wide a range of neurodegenerative diseases including orphan tauopathies, Alzheimer’s and Parkinson’s disease. Asceneuron has two clinical stage small molecule O-GlcNAcase inhibitors in development for the treatment of proteinopathies including Parkinson’s Disease, Alzheimer’s disease and related disorders. Asceneuron is a privately held company financed by a renowned syndicate of investors consisting of Sofinnova Partners, M Ventures, SR One, Johnson & … Type: | 3 | 2 | 2 | 20 |
 | Akadeum Life Sciences, Inc. Better Isolations. Healthier Cells. Akadeum Life Sciences® has developed a next generation platform that solves long-standing problems across cell therapy and other research, diagnostic and therapeutic markets. The proprietary buoyant microbubble technology platform addresses the need for high cell quality, scalability, time and workflow that current magnetic particle-based products commonly used in cell therapy manufacturing and research can’t address. The Company has several GMP grade and Clinical Ready kits to enable each stage of cell therapy manufacturers pipeline. Harnessing the microbubble capability, the AlerionTM Microbubble Cell Separation System enables cell isolation from tens of billions of cells in apheresis material … Type: | 1 | 1 | 0 | 31 |
 | Delphinus Medical Technologies, Inc. Delivering medical innovations to transform early detection of breast cancer and save women’s lives all over the world. Delphinus Medical Technologies, Inc. is an innovation leader in advanced ultrasound development, introducing a dynamic new technique to image the breast with the use of sound and water. Headquartered in Novi, MI, Delphinus is the first company to design and manufacture a whole breast ultrasound system that utilizes a ring transducer to transmit and receive ultrasound signals. Called SoftVueTM, and featuring proprietary TriADTM (triple acoustic detection) technology, the system captures reflection echoes from all directions around the breast and gathers transmitted signals … Type: | 1 | 1 | 0 | 65 |
 | Inscripta, Inc. The Digital Genome Engineering Company Inscripta® is a life science technology company committed to creating a cleaner, healthier, and more sustainable world through biomanufacturing. A global leader in genome engineering, our innovations are designed to unlock the full potential of the bioeconomy. We are committed to the continued development of critical technologies that enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta supports customers around the world from facilities in Pleasanton and Burlingame, California. To learn more, visit Inscripta.com and follow @InscriptaInc. Digital Genome Engineering, Gene Editing, Synthetic Biology, Genome Editing, CRISPR, … Type: | 4 | 1 | 3 | 74 |
 | Turbine We are building the world’s leading predictive simulation of patient biology. Truly meaningful medicine comes from breakthroughs?in deeply understanding patient biology. We are building the world’s leading predictive simulation of patient biology. We will empower the biopharma industry by informing the right experiments that identify and validate disease driving hidden effects. Drug Discovery, Biotechnology, Artificial Intelligence, in silico, Cell Biology, Simulated Experiments, Bioinformatics, and Pharmaceuticals Type: | 5 | 0 | 5 | 101 |
 | Insilico Medicine #insilicomeds, #drugdiscovery, #ai, #GANs, #GANs-RL, #DL #aging, #longevity Insilico Medicine, a clinical stage biotech company powered by generative AI, is connecting biology, chemistry, and clinical trials analysis using next-generation AI systems. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. Insilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. artificial intelligence, deep learning, reinforcement learning, drug discovery, … Type: | 20 | 2 | 17 | 295 |
 | The Medicine Maker The Medicine Maker celebrates the people, processes and vision that bring new drugs and biologics to market. The development and manufacture of new drugs and biological medicines draws on the talent, passion and experience of a wide range of professionals. The goal of The Medicine Maker is to bring this group into the limelight and, in doing so, to integrate the entire process, from the registration of an Investigational New Drug (IND) or Biologics License Application (BLA) through to the market launch of new therapies, and beyond. pharmaceutical , biopharmaceutical, bioprocess, upstream, downstream, formulation, drug delivery, and dosage form Type: | 29 | 6 | 27 | 1 |
 | Immunocore Science to Transform Lives Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases. See our community guidelines: http://bit.ly/2kFA8hr Biotechnology, Cancer, Oncology, Infectious Diseases, Autoimmune Diseases, T Cell Receptor, Immunotherapy, ImmTAX, ImmTAC, ImmTAV, and ImmTAAI Type: | 9 | 3 | 1 | 538 |
 | Crescendo Biologics Limited Crescendo Biologics - The T cell Enhancing Company Crescendo Biologics is a private, clinical stage immuno-oncology company developing novel, targeted T cell enhancing Humabody® therapeutics. Leading its proprietary pipeline, Crescendo Biologics has developed CB307, a novel half-life extended CD137 x PSMA Humabody for the selective activation of tumour-specific T cells exclusively within the tumour microenvironment. CB307 is designed to achieve a longer lasting anti-cancer effect whilst avoiding systemic toxicity, and the clinical programme for CB307 is underway in patients with PSMA positive solid tumours (NCT04839991). CB693 is a half-life extended CD137 x MSLN Humabody and is the second proprietary clinical … Type: | 5 | 3 | 4 | 50 |
 | CHAIN Biotechnology Ltd Superior and effective microbiome therapeutics CHAIN Biotechnology was founded in 2014, by serial entrepreneur Dr Edward Green, to exploit the therapeutic potential of Clostridia bacteria found in the human gut microbiome. CHAIN has built an impressive technical team of molecular biology, microbiology, microbiome and fermentation specialists focused on the biotechnology development of Clostridia. In addition, CHAIN leverages synthetic biology expertise from the Synthetic Biology Research Centre at the University of Nottingham. CHAIN has developed a proprietary microbial platform for drug delivery. The platform builds on core engineering skills and involves the development and use of engineered Clostridia to deliver specific … Type: | 1 | 0 | 1 | 11 |
 | Newcells Biotech Ltd In vitro models to accelerate clinical translation We’re here to accelerate your therapy’s journey through the complexities of drug discovery and development. Putting innovation at the forefront of our capabilities, industry-leading experts help you confidently and proactively answer critical questions around the safety and efficacy of your product with our gold-standard in vitro models. By harnessing the power of predictive data, we navigate this crucial step efficiently and cost-effectively to maximise the potential of your therapy achieving clinical and market success. By combining our unique expertise with cutting-edge technologies, we’ve created predictive in vitro models that offer targeted solutions to … Type: | 1 | 0 | 1 | 47 |
 | Genomics plc Transforming health, healthcare and drug discovery through the power of genomics We are a pioneering healthcare company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery. We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalized estimates of risk for all the common diseases and cancers, well ahead of … Type: | 12 | 4 | 11 | 148 |
![LCC [Liverpool ChiroChem]](/media/logo/101424.jpeg){kind=logo} | LCC [Liverpool ChiroChem] Bring new compounds to market faster, better, and easier. Liverpool ChiroChem is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs. LCC was established in Liverpool, United Kingdom, in June 2014. The company has developed a suite of synthetic methodologies that have been used to produce thousands of novel, multifunctional 3D-rich, chiral fragments/scaffolds/BB’s to support NCE discovery & development (e.g. Fragments, DEL, VLS, Bifunctional Linkers). LCC is continuously expanding its 3D chemical space and has recently launched a 1.4Bn member Ultra-Large Virtual Library designed based on its proprietary scaffolds and supported by … Type: | 2 | 0 | 0 | 30 |
 | Evox Therapeutics Ltd Naturally inspired. Engineered to deliver Evox Therapeutics is harnessing and engineering the natural trafficking capabilities of extracellular vesicles to develop an entirely novel class of biotherapeutics. By combining groundbreaking exosome technology from well-renowned Oxford University and the Karolinska Institutet – the home of the Nobel Prize – we aim to revolutionise the treatment of a broad range of severe disease, with profound implications for human health. Based in Oxford, UK, Evox Therapeutics was founded in 2016 by Professor Matthew Wood of Oxford University, Assistant Professor Samir EL Andaloussi and Dr Per Lundin of the Karolinska Institutet, to capitalise on foundational … Type: | 6 | 2 | 0 | 53 |
 | Closed Loop Medicine Treating the individual, not just the disease, through personalized and optimized dosing. We need to shift to a world where we treat the individual, not just the disease. Our inventions work in combination with medicine to deliver personalized, optimized dosing, to provide bespoke universal healthcare access and improve outcomes for patients with chronic diseases. Closed Loop Medicine is a TechBio company developing combination prescription drug + software products, with the aim of bringing forward the promise of precision care. Our proprietary technology platform facilitates personalized drug dose optimization through integration of medicines and software with patient-led digital experiences and closed … Type: | 10 | 1 | 5 | 54 |
 | 4Dcell Smart control of the cell microenvironment - Bioengineered in vitro assays Experts in cell microenvironment control. At the forefront of the new challenges in biology, 4Dcell offers more reliable innovative study models, which are closer to the natural environment of the cell. 4Dcell technologies provide solutions for a myriad of applications. Among them, we highlight models for cancer, immune system, organs such as heart or gut, circulating cells, wound healing, neuronal network, stem cells and genetic disorders such as laminopathy. Years of research have led 4Dcell to develop an innovative 3D cell culture technology that enables the acquisition of more … Type: | 2 | 1 | 1 | 13 |
 | VITROPEP To make syringe injections disappear! Vitropep customizes soluble microneedles patches made of biomaterials for transdermal injection Type: | 10 | 4 | 9 | 2 |
 | Orakl Oncology Orakl Oncology integrates best-in-class biology with high-quality patient data to transform oncology drug development. Orakl Oncology leverages a unique collection of patient tumor avatars that combines biology and clinical data to fuel the therapeutic arsenal to fight cancer. With our platform we partner with oncology players to identify relevant targets and deliver new drugs, faster. Type: | 1 | 1 | 0 | 12 |
 | En Carta Diagnostics Diagnostics for better care, everywhere. Diagnostics for Better care, Everywhere. En Carta Diagnostics is a synthetic-biology biotech company leveraging patented technologies to decentralise highly reliable molecular diagnostic solutions. synthetic biology, cell-free, biotech, and molecular sensing Type: | 5 | 3 | 3 | 6 |
 | EnsembleTM Foods Innovative plant-based products, powered by Tereos. At EnsembleTM Foods, we offer unique and simple plant-based products made primarily from a short list of main ingredients (stock, wheat protein, chickpeas, sunflower oil and potato fiber). We strive to make products from renewable raw materials that are high in protein and fiber and low in saturated fat (contains 5-7g Total Fat per serving). Ensemble's goal is to produce healthy, affordable, plant-based products to support feeding the world. Simply put, our mission is to be "good for you and good for the planet". Ensemble Foods is powered by @tereos , a cooperative of … Type: | 1 | 1 | 0 | 18 |
 | Cutting Edge SAS Over 20 years of experience dedicated to intraocular lenses manufacturing To design, develop and distribute innovative solutions in eye surgery contributing to patient well-being. We have over 20 years of experience dedicated to IOL manufacturing. Opthalmology, Intraocular Lenses, Medical Devices, Surgical, Cataract, Vitreoretinal, and Cornea Type: | 1 | 1 | 0 | 41 |
 | Altevax Biotech Altevax is developing a disruptive immunotherapy technology against cancer Altevax is developing a powerful pioneering immunotherapy technology against cancer. Its patented melanin-based technology has been proven in pre-clinical trials to boost an antigen-specific immune response with Cytotoxic T-lymphocytes (CD8+ Killer T cells), the body’s most powerful defenders. The Altevax immunotherapy technology works with a wide range of peptides. The Altevax technology is complementary to other anti-cancer immune technologies, such as anti PD1s. Altevax is developing an immunotherapy against glioblastoma, currently in advanced pre-clinical development, with Phase 1/2a expected in early 2024. Altevax's partnership with Assistance Publique Hôpitaux de Paris and … Type: | 11 | 3 | 5 | 6 |
 | AmyPore New target, new paradigm, new strategy that address the root cause of Alzheimer, Parkinson, and other proteinopathies AmyPore is a biotechnology company based around the leading science of Pr. Nouara Yahi (University of Aix-Marseillle) and Pr. Jacques Fantini (University of Aix-Marseille and Institut Universitaire de France). Their expertise in molecular neurosciences has led to the discovery of AmyP53, a first-in-class patented nontoxic molecule which tackles a common mechanism of neurotoxicity shared by Alzheimer and Parkinson diseases. The company applies its pioneering computational discovery platform coupled with high performance lipid-protein and protein-protein binding technology and ultrasensitive Ca2+ amyloid pore reporting assay … Type: | 1 | 1 | 0 | 1 |
 | Suricog SuriCog was founded in mid-2013 by Marc Massonneau, serial entrepreneur in medical devices & services, and some other passionate people, to develop new generation of gaze-based diagnostic tools in order to improve patient pathways in neurology and psychiatry. In 2016, we acquired a company which developed a 10M€ program for best-in-class eye-movement acquisition and analysis solutions in several key neurological diseases Drawing from over a quasi-decade of eye studies, algorithm development, optoelectronics design, high-end software, and clinical trials and applications, we have advanced our technology for integration in a data-driven complete solution, as the fundamental for medical oriented eye-tracking. The … Type: | 2 | 4 | 0 | 20 |
 | E-PHY-SCIENCE E-PHY-SCIENCE is a service company specialized in In-vivo and In-vitro electrophysiological assays. If you are currently developing a program in CNS disorder, we can help you increase your chances of success. By gathering on the same platform In-Vivo and In-Vitro electrophysiological assays, the E-PHY-SCIENCE team is able to offer you a complete range of studies. These assays can reveal specific abnormalities in many genetic models of human brain disease, as well as the effect of new molecules on normal brain functions. These types of experiment provide insights for new therapies as well as understandings of brain diseases mechanisms. We cover … Type: | 1 | 0 | 0 | 10 |
 | ProGeLife [Automatic translation follows] Innovative research solutions for rare diseases Development of drugs for the treatment of rare genetic diseases with premature or accelerated aging Type: | 0 | 0 | 0 | 9 |
 | ATLANTHERA Bone targeted delivery concept Atlanthera is a drug discovery company focused on bone diseases and bone cancer treatments Our vision: Be the leader in bone-targeted drug delivery to cure bone cancer and metastases Atlanthera can rely on a very high-qualified Team and a worldwide-known experts network Our concept: Bone-targeted delivery of anti-cancer drug www.atlanthera.com Watch our concept in video > https://youtu.be/m3BBWguO6hs Durg discovery, Bone-targeted drug delivery, Bone cancer, and Bone metastases Type: | 2 | 1 | 2 | 11 |
 | GOLIVER THERAPEUTICS Repair the liver without graft GOLIVER THERAPEUTICS is a spin-off from the INSERM and University of Nantes (CRTI UMR1064-ITUN-Nantes Hospital), focused on developing cell-based Advanced Therapy Medicinal Products (ATMP) to respond to an urgent unmet medical need in transplantation. GOLIVER THERAPEUTICS aims to become a Worldwide leader inregenerative medicine in providing the first cell-based therapy product for life-threatening liver failures. Type: | 5 | 1 | 5 | 31 |
 | OCRvet Your partner for comparative medicine studies Oncovet Clinical Research (O.C.R.) is an innovative Contract Research Organization specialized in the conception and management of clinical trials on Dogs & Cats models with naturally occurring pathologies for efficacy assessment of drug candidates for Human Health. O.C.R. innovative offer is at the forefront of ethics of research involving animals since Dogs & Cats included in clinical trials benefit from new therapies developed for Human. O.C.R. main therapeutic fields are Oncology, Inflammation, Cardiology & Neurology. O.C.R. proposes to support Pharma & Biotech in furthering their drug development programs (in preclinical & clinical phases) by … Type: | 3 | 1 | 1 | 21 |
 | METAFORA biosystems AI-Powered Cytometry & Cell Metabolism Profiling At Metafora, we develop innovative and impactful AI-powered cytometry & cell metabolism profiling solutions. We are passionate about cell biology. We leverage our unique cell metabolism and AI-powered data analysis platforms to turn disruptive single-cell technologies into impactful solutions that improve human health. biomarkeurs, cell metabolism, flow cytometry, data analysis, biotechnology, IVD tests, diagnostics, diagnostic tests, cell biology, neurometabolic diseases, metabolic diseases, oncology, multiple myeloma, and research Type: | 18 | 2 | 12 | 36 |
 | LiMM Therapeutics LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells. LiMM is the biopharmaceutical company harnessing the molecular cross-talk between neuronal and innate lymphoid cells within peripheral tissues. By decoding the language of the neuroimmune cross-talk, we are developing first-in-class therapeutic products – NRILs: neuronal reprogrammers of innate lymphocytes - to preserve health and treat inflammatory, infectious and metabolic diseases. We are bridging neural sensing and immunology discoveries to unlock therapeutic solutions for the benefit of patients. Type: | 0 | 0 | 0 | 4 |
 | EG 427 Pinpoint Gene Therapy At EG427 our unique, non-replicative Herpes Simplex Virus type 1 (HSV-1) based vector platform delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes to address prevalent diseases in neurology. Our lead asset EG110A, for the treatment of neurogenic bladder dysfunction, has received IND clearance in June 2024 from the US FDA. Our revolutionary approach to the treatment of this disease aims at providing patients with a comprehensive, long-term solution to their bladder management, through a highly selective molecular biology approach overcoming the drawbacks of current standard of care. Our HQ and labs are in … Type: | 2 | 2 | 0 | 23 |
 | Rarecells Detect and defeat cancer from its start through a simple blood draw. Rarecells develops and commercializes the ISET technology to isolate Circulating Cancer Cells for early cancer diagnosis and medical research. Rarecells® Diagnostics was created in 2010 by Patrizia Paterlini Brechot, Professor of Cell Biology and Oncology, in order to make the scientific and technological advances developed by her team available to research teams and patients. Rarecells® Diagnostics’ core product is the patented ISET® (Isolation by SizE of Tumor cells) Technology. Rarecells® Diagnostics has the exclusive license of patents belonging to the French Public Institutions University Paris Descartes, Assistance Publique … Type: | 1 | 1 | 0 | 22 |
 | Scipio bioscience Single-cell sequencing on every benchtop Scipio bioscience had to cease its operations on 18/09/2024. At Scipio bioscience we were passionate about empowering every researcher to discover the molecular mechanisms of life for better health and a sustainable world. Enabling deeper insights into disease understanding, Scipio wanted to boost the access to and increases the pace of discoveries with its Asteria benchtop kit for easy scRNA-seq sample preparation and its Cytonaut intuitive cloud-based data analysis software for biologists and bioinformaticians alike. Scipio provided all researchers with empowered autonomy to embrace the next step in single-cell, working with unaltered transcriptomic data for … Type: | 4 | 2 | 3 | 25 |
 | Innoskel Developing novel therapies for rare bone diseases Innoskel is a pioneering platform biotechnology company developing therapies for rare bone diseases. Innoskel's first asset is a treatment option for a group of rare skeletal disorders collectively known as type 2 collagenopathies, the most severe of which with symptoms present from birth is Spondyloepiphyseal Dysplasia congenita (SEDc), the second leading cause of dwarfism worldwide. Innoskel’s lead gene therapy asset for SEDc has demonstrated good efficacy in proof-of-concept studies. The company’s fundamental mission is to improve the lives of patients living with rare bone disorders and to answer their unmet needs, keeping their … Type: | 8 | 7 | 1 | 7 |
 | Affluent Medical [Automatic translation follows] Addressing unmet needs in structural heart disease, vascular therapy and urology. Affluent Medical is a new French medtech player with the ambition of becoming a European leader in the cardiovascular and urological fields. Affluent Medical develops innovative, next-generation, minimally invasive implants to restore essential physiological functions in these fields: - Kardiozis aims to prevent endoleaks and the risk of abdominal aortic aneurysm recurrence, allowing patients to live more peacefully in the face of an unpredictable risk of rupture; - Kalios and Epygon aim to offer more physiological surgical treatments for the repair or replacement of the heart's … Type: | 4 | 2 | 2 | 69 |
 | Evora Biosciences First-in-class immunomodulatory peptides. Evora Biosciences develops novel immunomodulatory peptides with the aim to bring first-in-class treatments to patients in areas of high unmet need. immunodermatology, peptides, inflammatory diseases, respiratory diseases, inflammation, and immunomodulation Type: | 5 | 3 | 2 | 7 |
 | Egle Therapeutics Modulating T-regulatory cells to balance immunity Egle Therapeutics has been founded with a vision to become a game changer in the field of immunomodulating T-regulatory cells (Tregs) through the unique concept of Tregs’ starving while specifically targeting the most immunosuppressive ones. Type: | 2 | 1 | 1 | 38 |
Startup